EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of antibodies against severe fever with thrombocytopenia syndrome virus nucleoprotein for diagnosis

Eun-Mee Park, Seheon Kim, Seoyoen Lim, Parastou Rahimizadeh, Hyeyoon Jeon, Hyung Jin Lim, Sungjin Lee, Yong Bhum Song

Applied Microbiology and Biotechnology · 2025

DOI: 10.1007/s00253-025-13530-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2025. Verfasst von Eun-Mee Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Antibodies, Viral, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Institute of Science and Technology Institutional Program, National Research Foundation (NRF) from the Korean government (MSIT), Research Grant from the Scripps Korea Antibody Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral infectious disease caused by a novel Bandavirus in the family Phenuiviridae. The SFTS virus (SFTSV) is transmitted to various hosts, including humans, through tick bites, leading to high fever, thrombocytopenia, and leukopenia, with a high case fatality rate (up to 30%) due to multiple organ dysfunction. Therefore, early diagnosis is crucial for effective treatment and preventing disease transmission. In this study, we aimed to develop and characterize monoclonal antibodies targeting the SFTSV nucleocapsid protein (NP). We generated recombinant NP to screen antibodies against SFTSV. Using phage display technology, we identified candidate single-chain variable fragment (scFv) sequences capable of detecting SFTSV NP. Five human IgG antibodies and six chimeric mouse antibodies exhibited strong binding ability to the recombinant NP. Furthermore, their specificity and selectivity were evaluated against NPs from different subtypes and other viral species. A sandwich enzyme-linked immunosorbent assay (ELISA) was performed to determine optimal antibody pairings for SFTSV detection. The mP01A05/hP01C09, mP01A05/hP01B10, and mP02E04/hP01A05 antibody pairs demonstrated high efficacy in diagnosing SFTSV infections. These findings provide valuable antibody resources and establish an effective platform for the diagnosis of SFTS. KEY POINTS: • Monoclonal antibodies targeting SFTSV NP were developed using phage display technology. • Candidate antibodies showed strong binding ability and high specificity to SFTSV NP. • Optimized antibody pairs enabled effective SFTSV detection via sandwich ELISA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Severe Fever with Thrombocytopenia SyndromePhlebovirusAntibodies, ViralAntibodies, MonoclonalNucleocapsid ProteinsNucleoproteinsAnimalsHumansSingle-Chain AntibodiesMiceEnzyme-Linked Immunosorbent AssayImmunoglobulin GRecombinant Proteins

Stichwörter der Autor:innen

DiagnosticsMonoclonal antibodyNucleocapsid proteinSevere fever with thrombocytopenia syndrome virus

Substanzen

Antibodies, ViralAntibodies, MonoclonalSingle-Chain AntibodiesNucleocapsid ProteinsNucleoproteinsImmunoglobulin GRecombinant Proteins

Autor:innen und Institutionen

  • Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea.
  • Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea. songyb8686@gmail.com.

Förderung

  • Korea Institute of Science and Technology Institutional Program
  • National Research Foundation (NRF) from the Korean government (MSIT)
  • Research Grant from the Scripps Korea Antibody Institute

Zitieren

APA

Park, E. M., Kim, S., Lim, S., Rahimizadeh, P., Jeon, H., Lim, H. J., Lee, S., & Song, Y. B. (2025). Development of antibodies against severe fever with thrombocytopenia syndrome virus nucleoprotein for diagnosis. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-025-13530-1

Vancouver

Park EM, Kim S, Lim S, Rahimizadeh P, Jeon H, Lim HJ, et al. Development of antibodies against severe fever with thrombocytopenia syndrome virus nucleoprotein for diagnosis. Applied Microbiology and Biotechnology. 2025. doi:10.1007/s00253-025-13530-1

BibTeX
@article{Park2025,
  author = {Park, Eun-Mee and Kim, Seheon and Lim, Seoyoen and Rahimizadeh, Parastou and Jeon, Hyeyoon and Lim, Hyung Jin and Lee, Sungjin and Song, Yong Bhum},
  title = {Development of antibodies against severe fever with thrombocytopenia syndrome virus nucleoprotein for diagnosis},
  journal = {Applied Microbiology and Biotechnology},
  year = {2025},
  doi = {10.1007/s00253-025-13530-1}
}
Kostenlos starten →